- Histologic diagnosis of squamous non-small cell lung cancer that has been treated adequately in the metastatic or unresectable setting with a platinum doublet chemotherapy regimen and an immune checkpoint inhibitor, and now has evidence of disease progression. Patients who have not received an immune checkpoint inhibitor must have medical reasons for not receiving such therapy, such as a prior history of an autoimmune disease.